Ascentage Pharma Group International (ASPHF)
USD 2.69
(0.0%)
USD 2.69
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 191.44 Million CNY | 1.99% |
| 2022 | 187.71 Million CNY | 663.62% |
| 2021 | 24.58 Million CNY | 134.47% |
| 2020 | 10.48 Million CNY | -15.57% |
| 2019 | 12.41 Million CNY | 82.42% |
| 2018 | 6.8 Million CNY | 7.57% |
| 2017 | 6.32 Million CNY | -14.56% |
| 2016 | 7.4 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q3 | 4.58 Million USD | -46.62% |
| 2023 Q4 | 4.71 Million USD | 2.86% |
| 2023 Q1 | 9.06 Million USD | 28.99% |
| 2023 FY | 191.44 Million CNY | 1.99% |
| 2023 Q2 | 8.58 Million USD | -5.35% |
| 2022 Q4 | 7.02 Million USD | 3.16% |
| 2022 Q2 | 9.18 Million USD | 0.0% |
| 2022 FY | 187.71 Million CNY | 663.62% |
| 2022 Q3 | 6.81 Million USD | -25.8% |
| 2021 Q2 | -640.45 Thousand USD | 0.0% |
| 2021 FY | 24.58 Million CNY | 134.47% |
| 2021 Q4 | 62.23 Thousand USD | 0.0% |
| 2020 FY | 10.48 Million CNY | -15.57% |
| 2020 Q2 | 372 Thousand USD | 0.0% |
| 2020 Q4 | -858.58 Thousand USD | 0.0% |
| 2019 Q2 | 342.8 Thousand USD | 0.0% |
| 2019 Q4 | -556.83 Thousand USD | 0.0% |
| 2019 FY | 12.41 Million CNY | 82.42% |
| 2018 FY | 6.8 Million CNY | 7.57% |
| 2017 FY | 6.32 Million CNY | -14.56% |
| 2016 FY | 7.4 Million CNY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -249298.783% |
| CSL Limited | 7.56 Billion USD | 97.468% |
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | -1176.358% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -6171434.494% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 11.7 Million USD | -1535.409% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | -60.729% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 560688.58% |
| Mesoblast Limited | -35.16 Million USD | 644.361% |
| Marizyme, Inc. | 457.7 Thousand USD | -41726.56% |
| Genus plc | 178.7 Million USD | -7.13% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -46574.143% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 1740472.727% |
| ContraFect Corporation | -154 Thousand USD | 124412.338% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 382982.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| IMV Inc. | -962.29 Thousand USD | 19994.149% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 49504.002% |
| MultiCell Technologies, Inc. | 49.32 USD | -388160889.457% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | -375.453% |
| EV Biologics, Inc. | 48.9 Thousand USD | -391394.888% |
| Q BioMed Inc. | -8988.00 USD | 2130062.172% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | -577.547% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 1241289.056% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -273387.143% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 154176.024% |
| SQZ Biotechnologies Company | 9.79 Million USD | -1854.676% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 3866032.956% |
| Arch Therapeutics, Inc. | -2439.00 USD | 7849259.492% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -291162.476% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -136156.94% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 13.022% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -307554.357% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 196419.541% |
| GB Sciences, Inc. | -624.00 USD | 30679747.436% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 222633.361% |
| argenx SE | 1.1 Billion USD | 82.729% |
| HST Global, Inc. | - USD | -Infinity% |
| Halberd Corporation | -208.00 USD | 92039042.308% |
| Enzolytics Inc. | 30.7 Thousand USD | -623323.863% |
| Resverlogix Corp. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | -39582.401% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 842.077% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | -331.583% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 16869.945% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 37308.412% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -30908.416% |
| ONE Bio Corp. | 20.12 Million USD | -851.239% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 53.256% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 2161809.575% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 228416.378% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 30480.805% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | -19276.992% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | -1891.895% |
| BioStem Technologies, Inc. | 15.42 Million USD | -1141.121% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 1617683.439% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 396794.917% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -108328.296% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -108328.296% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | -14006.177% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 660241.379% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | -42438.38% |
| SYBLEU INC | 11.69 Thousand USD | -1636707.456% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 60017.623% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | -4054.536% |
| Bioxytran, Inc. | -8285.00 USD | 2310794.025% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 51424.665% |
| Neutra Corp. | 14.33 Thousand USD | -1335379.595% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 233564.634% |
| PureTech Health plc | -1.6 Million USD | 12042.67% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 19220.467% |
| IXICO plc | 3.27 Million USD | -5754.465% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 27685.159% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 10789.056% |
| CSL Limited | 7.7 Billion USD | 97.515% |
| Cellectis S.A. | 18 Thousand USD | -1063461.111% |